drugset / Trial / NCT02055963

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer

NCT02055963

RandomizedParallel-groupDouble-blindSupportive care

Summary

The goal of this clinical research study is to learn if Minocin® (minocycline) can reduce certain side effects of surgery in patients with head and neck cancer (such as pain, fatigue, and disturbed sleep). In this study, minocycline will be compared to a placebo. A placebo is not a drug. It looks like the study drug, but it is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.

Timeline

Start
2014-05-06
Primary completion
2022-08-11
Completion
2022-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral

Indications